AKT1 and gastric carcinoma: In summary, our results indicate that AT-II exerts anti-cancer effects by inhibiting proliferation, motility and inducing apoptosis and may be due to inactivating Ras/ERK and PI3K/Akt signaling pathways, which might shed light on therapy of gastric carcinoma.